Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Biotechnology

Health Care

Health Diagnostics

Exosome Diagnostics

Exosome Diagnostics' headquarters in New York, NY, United States

Benjamin Sawicki

Chelsea S.

Dan Baughman

Johan Skog

Kelli Neary

Kaitlyn Xavier

Lorinda Hedstrom

Brian Raifsnider

Katelyn Silk

Chris Bentis

Frances Perez

Matthew Dindinger

Cheryl Amadi

John Lagorio

Katherine Towey

Joshua Merryman

Bolade Olambiwonnu

Nancy Donovan

Michael Gendelman

Joseph Wiggins

Maura Sissler

Emily Mitsock

Brittany Lemos

The Sales and Account Management team at Exosome Diagnostics is responsible for driving the adoption of the company's biofluid-based molecular diagnostic tests within the healthcare market. They engage with healthcare providers and laboratories, fostering relationships and delivering tailored solutions to meet client needs. By leveraging their expertise in personalized medicine, the team ensures that clients understand the benefits of using exosome technology for diagnosing diseases, ultimately contributing to improved patient outcomes.

Sales and Account Management

The Research and Development team at Exosome Diagnostics is responsible for innovating and optimizing biofluid-based diagnostic tests that leverage exosomes for personalized medicine. This team collaborates on designing experiments, developing and validating assays, and advancing the understanding of disease-specific nucleic acids to ensure high sensitivity and specificity in detecting rare gene transcripts. Their work is crucial for the progression of accurate molecular diagnostics in clinical settings.

Research and Development

The Engineering and Quality Assurance team at Exosome Diagnostics specializes in developing and maintaining the technological systems that process biofluid samples and ensure the accuracy and reliability of molecular diagnostic tests. They integrate advanced software solutions and automation to optimize workflows and employ rigorous quality assurance practices to meet regulatory standards, thereby enhancing the sensitivity and specificity of diagnostic results.

Engineering and Quality Assurance

The Finance and Accounting team at Exosome Diagnostics is responsible for managing the company's financial operations, ensuring accurate billing and revenue collection, and maintaining robust financial reporting and compliance. They work collaboratively to support the growth of the company through meticulous oversight of financial transactions, budgeting, and customer service related to laboratory billing, ultimately enabling the advancement of innovative molecular diagnostic tests.

Finance and Accounting

��

Exosome Diagnostics

Org chart

Teams

Sales and Account Management

Research and Development

Engineering and Quality Assurance

Finance and Accounting

Offices

��������

Exosome Diagnostics

Org chart

Teams

Sales and Account Management

Research and Development

Engineering and Quality Assurance

Finance and Accounting

Offices

Related companies

��